Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 955
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
for
Advanced Malignant Solid Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT05705492
Phase 2, Recruiting
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
for
Castration Resistant Prostate Cancer,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: Male
Age: 18+
Code: NCT05919329
Phase 4, Recruiting
Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
for
Head and Neck Carcinoma, Hypopharyngeal Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT07857655
Recruiting
Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder
for
Familial Platelet Disorder With Associated Myeloid Malignancy
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07844694
Phase 1, Recruiting
Mammogram Pretreatment With Ulipristal Acetate
for
Mammography Screening, Breast Density
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: Female
Age: 18 - 50
Code: NCT07434128
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07726602
Recruiting
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT04529044
Phase 2, Recruiting
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
for
Prostate Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: Male
Age: 65+
Code: NCT07504835
Recruiting
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
for
Advanced Biliary Tract Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07405086
Phase 4, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Portland OR, Seattle WA, Salt Lake City UT, Billings MT,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Identifying and Caring for Individuals With Inherited Cancer Syndrome
for
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT04494945
Recruiting
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18 - 65
Code: NCT07228273
Phase 2, Recruiting
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors
Location: Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: FoRx Therapeutics AG
Sex: All
Age: 18+
Code: NCT07356453
Phase 1, Recruiting
Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT
for
Thrombosis
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07498517
Phase 2, Recruiting
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
for
Acute Myeloid Leukemia
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07548983
Phase 1, Recruiting
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome,
Location: Portland OR, Dallas TX, Columbus OH
Sponsor: Jennifer Saultz
Sex: All
Age: 18+
Code: NCT03874052
Phase 1, Recruiting
Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06562777
Recruiting
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps